1. "2006"
Formats
  1. Journal Article (1563)
  2. Meeting Abstract (688)
  3. Book Section (109)
  4. Conference Paper (22)
  5. Book Whole (12)
Groups
  1. Department of Medicine (642)
  2. Surgery (542)
  3. Sloan Kettering Institute Faculty (455)
  4. GSK Faculty (452)
  5. Solid Tumor Oncology Division (355)
  6. Survivorship Research (327)

More Groups

People
  1. Victor Reuter (56)
  2. Peter Scardino (51)
  3. Clifford Hudis (43)
  4. Michael Zelefsky (41)
  5. Andrew Vickers (40)
  6. Marc Ladanyi (38)

More People

Years
  1. 2006 (2394)
Publications
  1. Journal of Clinical Oncology (179)
  2. Blood (81)
  3. Cancer Research (76)
  4. Modern Pathology (70)
  5. Laboratory Investigation (60)
  6. International Journal of Radiation Oncology, Biology, Physics (57)

More Publications

Publishers
  1. Elsevier Inc. (248)
  2. American Society of Clinical Oncology (179)
  3. Nature Publishing Group (147)
  4. Springer (147)
  5. Elsevier Science, Inc. (128)
  6. Lippincott Williams & Wilkins (124)

More Publishers

Results (2394)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pharmacological profile of a microtubule stabilization agent, isooxazole-fludelone and its therapeutic effects against human tumor xenografts
    Meeting Abstract

    Chou, T.; Zhang, X.; Wu, N.; Yin, Y. I.; Li, Y.; Zhang, D.; Myles, D. C.; Danishefsky, S. J.
    Cancer Research (2006)

    Fulltext@MSK | Save
  • Therapeutic evaluation of the second generation epothilone, dehydelone, as a microtubule stabilization antitumor agent in xenograft models
    Meeting Abstract

    Chou, T.; Zhang, X.; Dong, H.; Chen, L.; Tan, Q.; Wu, N.; Yin, Y. I.; Danishefsky, S. J.
    Cancer Research (2006)

    Fulltext@MSK | Save
  • Design and development of purine-scaffold inhibitors of the heat shock protein 90
    Meeting Abstract

    Chiosis, G.
    Abstracts of Papers of the American Chemical Society (2006)

    Fulltext@MSK | Save
  • Cysteine cathepsin inhibition in combination with a maximum-tolerated dose and metronomic dose "chemo-switch" regimen leads to tumor regression and an overall survival benefit in a marine model of cancer
    Meeting Abstract

    Bell-Mcguinn, K. M.; Bogyo, M.; Hanahan, D.; Joyce, J.
    Cancer Research (2006)

    Fulltext@MSK | Save
  • Acquired resistance to EGFR tyrosine kinase inhibitors in lung cancer
    Meeting Abstract

    Balak, M. N.; Riely, G. J.; Li, A. R.; Zakowski, M. F.; Ladanyi, M.; Miller, V. A.; Pao, W.
    Cancer Research (2006)

    Fulltext@MSK | Save
  • The differentiation-related gene-1 (Drg1) inhibits chemotherapy-induced apoptosis by stabilizing Bcl-2 through direct binding
    Meeting Abstract

    Ambrosini, G.; Seelman, S. L.; Schwartz, G. K.
    Cancer Research (2006)

    Fulltext@MSK | Save
  • Possible conflicts between truthful communication and hope in patients with advanced cancer and their impact on making decisions about life support and advance directives
    Meeting Abstract

    Zhukovsky, D.; Coyle, N.; Cassell, E.
    Journal of Palliative Care (2006)

    Fulltext@MSK | Save
  • Something in common for lung and endometrial carcinoma
    Meeting Abstract

    Zhu, L.; Moreira, A. L.; Mittal, K.; Zhu, C.; Chiriboga, L.; Cassai, N. D.; Sidhu, G. S.
    Modern Pathology (2006)

    Fulltext@MSK | Save
  • Something in common for lung and endometrial carcinoma
    Meeting Abstract

    Zhu, L.; Moreira, A. L.; Mittal, K.; Zhu, C.; Chiriboga, L.; Cassai, N. D.; Sidhu, G. S.
    Laboratory Investigation (2006)

    Fulltext@MSK | Save
  • Increased calreticulin expression in clonal plasma cells is associated with complete response to melphalan and autologous stem cell transplant in systemic light-chain amyloidosis
    Meeting Abstract

    Zhou, P.; Olshen, A. B.; Teruya-Feldstein, J.; Comenzo, R.
    Blood (2006)

    Fulltext@MSK | Save